436 related articles for article (PubMed ID: 28633446)
1. Genetic Indicators of Drug Resistance in the Highly Repetitive Genome of Trichomonas vaginalis.
Bradic M; Warring SD; Tooley GE; Scheid P; Secor WE; Land KM; Huang PJ; Chen TW; Lee CC; Tang P; Sullivan SA; Carlton JM
Genome Biol Evol; 2017 Jun; 9(6):1658-1672. PubMed ID: 28633446
[TBL] [Abstract][Full Text] [Related]
2. Population structure and genetic diversity of the parasite Trichomonas vaginalis in Bristol, UK.
Hawksworth J; Levy M; Smale C; Cheung D; Whittle A; Longhurst D; Muir P; Gibson W
Infect Genet Evol; 2015 Aug; 34():36-43. PubMed ID: 26051885
[TBL] [Abstract][Full Text] [Related]
3. High rates of double-stranded RNA viruses and Mycoplasma hominis in Trichomonas vaginalis clinical isolates in South Brazil.
da Luz Becker D; dos Santos O; Frasson AP; de Vargas Rigo G; Macedo AJ; Tasca T
Infect Genet Evol; 2015 Aug; 34():181-7. PubMed ID: 26160539
[TBL] [Abstract][Full Text] [Related]
4. Trichomonas vaginalis metronidazole resistance is associated with single nucleotide polymorphisms in the nitroreductase genes ntr4Tv and ntr6Tv.
Paulish-Miller TE; Augostini P; Schuyler JA; Smith WL; Mordechai E; Adelson ME; Gygax SE; Secor WE; Hilbert DW
Antimicrob Agents Chemother; 2014 May; 58(5):2938-43. PubMed ID: 24550324
[TBL] [Abstract][Full Text] [Related]
5. Extensive genetic diversity, unique population structure and evidence of genetic exchange in the sexually transmitted parasite Trichomonas vaginalis.
Conrad MD; Gorman AW; Schillinger JA; Fiori PL; Arroyo R; Malla N; Dubey ML; Gonzalez J; Blank S; Secor WE; Carlton JM
PLoS Negl Trop Dis; 2012; 6(3):e1573. PubMed ID: 22479659
[TBL] [Abstract][Full Text] [Related]
6. Drug targets and mechanisms of resistance in the anaerobic protozoa.
Upcroft P; Upcroft JA
Clin Microbiol Rev; 2001 Jan; 14(1):150-64. PubMed ID: 11148007
[TBL] [Abstract][Full Text] [Related]
7. The genetic diversity of metronidazole susceptibility in Trichomonas vaginalis clinical isolates in an Egyptian population.
Abdel-Magied AA; El-Kholya EI; Abou El-Khair SM; Abdelmegeed ES; Hamoudaa MM; Mohamed SA; El-Tantawy NL
Parasitol Res; 2017 Nov; 116(11):3125-3130. PubMed ID: 28956167
[TBL] [Abstract][Full Text] [Related]
8. Trichomonas vaginalis prevalence, incidence, risk factors and antibiotic-resistance in an adolescent population.
Krashin JW; Koumans EH; Bradshaw-Sydnor AC; Braxton JR; Evan Secor W; Sawyer MK; Markowitz LE
Sex Transm Dis; 2010 Jul; 37(7):440-4. PubMed ID: 20351623
[TBL] [Abstract][Full Text] [Related]
9. The presence of dsRNA virus in Trichomonas vaginalis isolates from symptomatic and asymptomatic Indian women and its correlation with in vitro metronidazole sensitivity.
Malla N; Kaul P; Sehgal R; Gupta I
Indian J Med Microbiol; 2011; 29(2):152-7. PubMed ID: 21654110
[TBL] [Abstract][Full Text] [Related]
10. A systematic review of the literature on mechanisms of 5-nitroimidazole resistance in
Graves KJ; Novak J; Secor WE; Kissinger PJ; Schwebke JR; Muzny CA
Parasitology; 2020 Nov; 147(13):1383-1391. PubMed ID: 32729451
[TBL] [Abstract][Full Text] [Related]
11. Auranofin inactivates Trichomonas vaginalis thioredoxin reductase and is effective against trichomonads in vitro and in vivo.
Hopper M; Yun JF; Zhou B; Le C; Kehoe K; Le R; Hill R; Jongeward G; Debnath A; Zhang L; Miyamoto Y; Eckmann L; Land KM; Wrischnik LA
Int J Antimicrob Agents; 2016 Dec; 48(6):690-694. PubMed ID: 27839893
[TBL] [Abstract][Full Text] [Related]
12. Hydrogenosomes of laboratory-induced metronidazole-resistant Trichomonas vaginalis lines are downsized while those from clinically metronidazole-resistant isolates are not.
Wright JM; Webb RI; O'Donoghue P; Upcroft P; Upcroft JA
J Eukaryot Microbiol; 2010; 57(2):171-6. PubMed ID: 20015182
[TBL] [Abstract][Full Text] [Related]
13. [Investigation of in vitro metronidazole resistance in the clinical isolates of Trichomonas vaginalis].
Ertabaklar H; Yaman Karadam S; Malatyalı E; Ertuğ S
Mikrobiyol Bul; 2016 Oct; 50(4):552-558. PubMed ID: 28124960
[TBL] [Abstract][Full Text] [Related]
14. Molecular typing of the actin gene of Trichomonas vaginalis isolates by PCR-RFLP in Iran.
Momeni Z; Sadraei J; Kazemi B; Dalimi A
Exp Parasitol; 2015 Dec; 159():259-63. PubMed ID: 26542260
[TBL] [Abstract][Full Text] [Related]
15. Molecular epidemiology of metronidazole resistance in a population of Trichomonas vaginalis clinical isolates.
Snipes LJ; Gamard PM; Narcisi EM; Beard CB; Lehmann T; Secor WE
J Clin Microbiol; 2000 Aug; 38(8):3004-9. PubMed ID: 10921968
[TBL] [Abstract][Full Text] [Related]
16. Trichomonads, hydrogenosomes and drug resistance.
Kulda J
Int J Parasitol; 1999 Feb; 29(2):199-212. PubMed ID: 10221623
[TBL] [Abstract][Full Text] [Related]
17. Drug resistance in the sexually transmitted protozoan Trichomonas vaginalis.
Dunne RL; Dunn LA; Upcroft P; O'Donoghue PJ; Upcroft JA
Cell Res; 2003 Aug; 13(4):239-49. PubMed ID: 12974614
[TBL] [Abstract][Full Text] [Related]
18. The flavin inhibitor diphenyleneiodonium renders Trichomonas vaginalis resistant to metronidazole, inhibits thioredoxin reductase and flavin reductase, and shuts off hydrogenosomal enzymatic pathways.
Leitsch D; Kolarich D; Duchêne M
Mol Biochem Parasitol; 2010 May; 171(1):17-24. PubMed ID: 20093143
[TBL] [Abstract][Full Text] [Related]
19. The Role of Iron Status in the Early Progression of Metronidazole Resistance in Trichomonas vaginalis Under Microaerophilic Conditions.
Argáez-Correa W; Alvarez-Sánchez ME; Arana-Argáez VE; Ramírez-Camacho MA; Novelo-Castilla JS; Coral-Martínez TI; Torres-Romero JC
J Eukaryot Microbiol; 2019 Mar; 66(2):309-315. PubMed ID: 30047563
[TBL] [Abstract][Full Text] [Related]
20. Mycoplasma hominis infection of Trichomonas vaginalis is not associated with metronidazole-resistant trichomoniasis in clinical isolates from the United States.
Butler SE; Augostini P; Secor WE
Parasitol Res; 2010 Sep; 107(4):1023-7. PubMed ID: 20652315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
